Assessment of global cardiovascular risk and risk factors in Portugal according to the SCORE® model
- First Online:
- 64 Downloads
Cardiovascular diseases (CVD) are the leading cause of mortality in European countries. This study aimed at estimating the 10-year risk of fatal CVD in Portuguese adults and to assess the prevalence of major cardiovascular risk factors, according to the SCORE® risk prediction system.
Subjects and methods
A cross-sectional survey was carried out in 60 community pharmacies (CP) from October 2005 to January 2006 in a sample of CP users (≥40 and ≤65 years). Data were collected by patient interviews using a structured questionnaire applied by a trained pharmacist.
A total of 1,043 individuals were enrolled in the study (participation rate: 91%). The mean age was 53.7 years (SD: 7.1) with a ratio men/women of 0.68. The average risk in the sample was 1.94 (minimum 0, maximum 28, SD =2.69). About 20% of the studied adults were at high risk, of which 39.4% were asymptomatic. CV risk was significantly higher in the oldest age group and in men (p < 0.05). The prevalence of main CV risk factors was: hypertension-54.8%; hypercholesterolemia-63.1%, diabetes-13.4%; smoking-10.4% and obesity–29.0%. About 1/3 of those asked had family history of premature CVD. Mean values of biochemical and clinical parameters were: systolic blood pressure (mmHg): 134.8 ± 19.7; diastolic blood pressure (mmHg): 81.0 ± 11.4; total cholesterol (mg/dl): 193.8 ± 34.6; body mass index (kg/m2): 28.0 ± 4.5.
According to SCORE®, about one-fifth of the individuals was classified as high risk, and 7.7% was asymptomatic. CV risk was significantly higher in the oldest age group (55–65 years old) and in men (p < 0.05). These results show a high prevalence of some risk factors, particularly hypertension and hypercholesterolemia.
KeywordsCardiovascular risk estimation Cardiovascular risk factors Epidemiology Portugal SCORE® risk chart
- Amariles P, Machuca M, Jimenez-Faus A, Silva-Castro MM, Sabater D, Baena MI et al (2004) Cardiovascular risk: components, evaluation and preventative interventions. Ars Pharmaceutica 45(3):187–210Google Scholar
- Atthobari J, Monster TB, De Jong PE, De Jong-van den Berg LT (2004) Prevention Study Group-The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs. Br J Clin Pharmacol 57(3):328–36PubMedCrossRefGoogle Scholar
- Buitrago F, Canon-Barroso L, Diaz-Herrera N, Cruces-Muro E, Escober-Fernandez M, Serrano-Arias JM (2007) Comparison of the REGICOR and SCORE function charts for classifying cardiovascular risk and for selecting patients for hypolipidemic or antihypertensive treatment. Rev Esp Cardiol 60(2):139–47PubMedCrossRefGoogle Scholar
- Costa J, Borges M, Oliveira E, Gouveia M, Vaz Carneiro A (2003) Incidence and Prevalence of Hypercholesterolemia in Portugal: a systematic review. Part III. Rev Port Cardiol 22(6):829–836Google Scholar
- European guidelines on cardiovascular prevention in clinical practice (2003) Eur J Cardiovasc Prev Rehabil 10(suppl 1):1–78Google Scholar
- Expert Panel on the Identification, Evaluation and Treatment of Overweight in adults (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 68:899–917Google Scholar
- Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A (2005) European cardiovascular disease statistics. BHF, LondonGoogle Scholar
- Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE et al (2006) Pharmacy and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc (Wash DC) 46(3):370–377Google Scholar
- World Health Organization. International Society of Hypertension. Guidelines for the management of hypertension (1999) Guidelines Subcommittee. J Hypertens 17:151–183Google Scholar
- WHO Regional Publications (2002) The European Health report. WHO Europe. European Series, CopenhagenGoogle Scholar
- WHO Regional Publications (2005) European Cardiovascular disease statistics-2005 edition. WHO Europe. European Series, CopenhagenGoogle Scholar